Clinical Anesthesia Procedures
Dantrolene
Indications
Malignant hyperthermia (MH); neuroleptic malignant syndrome.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Pino, Richard M., editor. "Dantrolene." Clinical Anesthesia Procedures, 10th ed., Wolters Kluwer, 2022. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728025/1/Dantrolene.
Dantrolene. In: Pino RMR, ed. Clinical Anesthesia Procedures. Wolters Kluwer; 2022. https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728025/1/Dantrolene. Accessed July 21, 2025.
Dantrolene. (2022). In Pino, R. M. (Ed.), Clinical Anesthesia Procedures (10th ed.). Wolters Kluwer. https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728025/1/Dantrolene
Dantrolene [Internet]. In: Pino RMR, editors. Clinical Anesthesia Procedures. Wolters Kluwer; 2022. [cited 2025 July 21]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728025/1/Dantrolene.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dantrolene
ID - 728025
ED - Pino,Richard M,
BT - Clinical Anesthesia Procedures
UR - https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728025/1/Dantrolene
PB - Wolters Kluwer
ET - 10
DB - Anesthesia Central
DP - Unbound Medicine
ER -
